Literature DB >> 11984959

[Epstein-Barr virus infection in patients after bone marrow and heart transplantation].

B Zawilińska1, K Gruszka, B Piatkowska-Jakubas, M Garlicki, A Skotnicki.   

Abstract

UNLABELLED: Epstein-Barr virus (EBV) infections in immunosuppressed patients cause the severe clinical problems. Posttransplant lymphoproliferative disease (PTLD) might occur as a result of the latent EBV activation.
OBJECTIVE: Occurrence of active EBV infection in heart and bone marrow transplant patients.
METHODS: 68 serum samples obtained from 13 allogenic bone marrow and 20 heart transplant patients were tested by IF and ELISA methods. Antibodies against VCA, EA and EBNA antigens were measured.
RESULTS: All patients showed the presence of anti-VCA IgG antibodies, thus all were seropositive. Three patients (9%) showed primary EBV infection while in 12 (36%) patients virus reactivation or reinfection was confirmed.
CONCLUSIONS: 1. EBV infection in immunosuppressed patients is mainly caused by latent virus reactivation. 2. Type of EBV infection can be confirmed serologically only by the detection of specific anti-VCA, EA and EBNA antibodies. 3. The risk of PTLD in transplant patients creates the need for frequent monitoring.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11984959

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  1 in total

1.  High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.

Authors:  E Peres; S Savasan; J Klein; M Abidi; R Dansey; E Abella
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.